Poseida Therapeutics, Inc. Operating Cash Flow
Poseida Therapeutics, Inc. reported Operating Cash Flow of $13.72 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2024-11-07
- Poseida Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-09-30 was -$9.59M, a 221.63% decline year-over-year.
- Poseida Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-06-30 was $38.45M.
- Poseida Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-03-31 was -$15.13M.
- Poseida Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was -$28.74M, a 1296.17% decline year-over-year.
- Poseida Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$92.17M.
- Poseida Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$26.77M.
- Poseida Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$102.54M.
- Poseida Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$113.33M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2024-09-30 | -$9.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $28.86M derived: sum of 2 quarters · filed 2024-11-07 | $13.72M 10-Q · filed 2024-11-07 | -$15.02M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2024-06-30 | $38.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $23.32M 10-Q · filed 2024-08-05 | -$5.43M derived: sum of 3 quarters · filed 2024-08-05 | $2.46M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2024-03-31 | -$15.13M 10-Q · filed 2024-05-14 | -$43.88M derived: sum of 2 quarters · filed 2024-05-14 | -$35.99M derived: sum of 3 quarters · filed 2024-11-07 | -$69.30M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-12-31 | -$28.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$20.86M derived: sum of 2 quarters · filed 2024-11-07 | -$54.16M derived: sum of 3 quarters · filed 2024-11-07 | -$92.17M 10-K · filed 2024-03-07 | |
| 2023-09-30 | $7.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$25.42M derived: sum of 2 quarters · filed 2024-11-07 | -$63.42M 10-Q · filed 2024-11-07 | -$61.02M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | -$33.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$71.31M 10-Q · filed 2024-08-05 | -$68.91M derived: sum of 3 quarters · filed 2024-08-05 | -$7.03M derived: sum of 4 quarters · filed 2024-08-05 | |
| 2023-03-31 | -$38.01M 10-Q · filed 2024-05-14 | -$35.60M derived: sum of 2 quarters · filed 2024-05-14 | $26.28M derived: sum of 3 quarters · filed 2024-05-14 | -$13.45M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $64.28M derived: sum of 2 quarters · filed 2024-03-07 | $24.55M derived: sum of 3 quarters · filed 2024-03-07 | -$26.77M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $61.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $22.15M derived: sum of 2 quarters · filed 2023-11-09 | -$29.18M 10-Q · filed 2023-11-09 | -$20.70M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | -$39.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$91.05M 10-Q · filed 2023-08-08 | -$82.58M derived: sum of 3 quarters · filed 2023-08-08 | -$123.45M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | -$51.32M 10-Q · filed 2023-05-09 | -$42.85M derived: sum of 2 quarters · filed 2023-05-09 | -$83.72M derived: sum of 3 quarters · filed 2023-05-09 | -$114.81M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $8.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$32.40M derived: sum of 2 quarters · filed 2023-03-09 | -$63.49M derived: sum of 3 quarters · filed 2023-03-09 | -$102.54M 10-K · filed 2023-03-09 | |
| 2021-09-30 | -$40.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$71.96M derived: sum of 2 quarters · filed 2022-11-10 | -$111.02M 10-Q · filed 2022-11-10 | -$141.33M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$31.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$70.14M 10-Q · filed 2022-08-11 | -$100.46M derived: sum of 3 quarters · filed 2022-08-11 | -$129.79M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$39.06M 10-Q · filed 2022-05-12 | -$69.37M derived: sum of 2 quarters · filed 2022-05-12 | -$98.70M derived: sum of 3 quarters · filed 2022-05-12 | -$129.50M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$30.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$59.64M derived: sum of 2 quarters · filed 2022-03-10 | -$90.44M derived: sum of 3 quarters · filed 2022-03-10 | -$113.33M 10-K · filed 2022-03-10 | |
| 2020-09-30 | -$29.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$60.13M derived: sum of 2 quarters · filed 2021-11-09 | -$83.01M 10-Q · filed 2021-11-09 | -$99.58M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2020-06-30 | -$30.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$53.69M 10-Q · filed 2021-08-12 | -$70.25M derived: sum of 3 quarters · filed 2021-08-12 | -$89.42M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$22.89M 10-Q · filed 2021-05-11 | -$39.45M derived: sum of 2 quarters · filed 2021-05-11 | -$58.62M derived: sum of 3 quarters · filed 2021-05-11 | ||
| 2019-12-31 | -$16.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$35.73M derived: sum of 2 quarters · filed 2021-03-11 | -$64.52M 10-K · filed 2021-03-11 | -$64.40M 10-Q · filed 2020-08-20 | |
| 2019-09-30 | -$19.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$47.95M 10-Q · filed 2020-11-12 | |||
| 2019-06-30 | -$28.78M 10-Q · filed 2020-08-20 |